A severe case of pachyonychia congenita type I due to a novel proline mutation in keratin 6a

British Journal of Dermatology

Volumn 152, Issue 4, 2005, Pages 800-802

  Garcia Rio I ^a   Penas P F ^a   Garcia Diez A ^a   McLean, W H I ^b   Smith, Frances J D ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHROMIUM MERCURY SOLUTION; COAL TAR; CORTICOSTEROID; CYTOKERATIN 6; CYTOKERATIN 6A; EMOLLIENT AGENT; ERYTHROMYCIN; ETRETINATE; IBUPROFEN; KERATOLYTIC AGENT; LUBRICATING AGENT; MERCURY DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROLINE; RETINOID; RETINOL; SALICYLIC ACID; THREONINE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CLINICAL FEATURE; CONGENITAL PACHYONYCHIA; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEMALE; GENE MUTATION; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; KERATINOCYTE; LYMPHOCYTIC INFILTRATION; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SKIN BIOPSY;

ADULT; AMINO ACID SEQUENCE; ECTODERMAL DYSPLASIA; FEMALE; HUMANS; KERATINS; KERATODERMA, PALMOPLANTAR; KERATOSIS; MOUTH DISEASES; MUTATION, MISSENSE; NAILS, MALFORMED; PROLINE; SYNDROME;

EID: 17644395650     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06473.x     Document Type: Article

References (10)

1. Munro CS. Pachyonychia congenita: mutations and clinical presentations. Br J Dermatol 2001; 144:929-30.
2. Carroll MA, Kim HJ, Skidmore RA. What syndrome is this? Pachyonychia congenita. Pediatr Dermatol 1997; 14:491-3.
3. Irvine AD, McLean WHI. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999; 140:815-28.
4. Smith F. The molecular genetics of keratin, disorders. Am J Clin Dermatol 2003; 4:347-64.
5. Smith FJD, McKenna KE, Irvine AD et al. A mutation detection strategy for the human K6A gene and novel mutations in two cases of pachyonychia congenita type 1. Exp Dermatol 1999; 8:109-14.
6. Smith FJD, Del Monaco M, Steijlen PM et al. Novel proline substitution mutations in keratin 16 in two cases of pachyonychia congenita type 1. Br J Dermatol 1999; 141:1010-16.
7. Covello SP, Smith FJD, Sillevis Smitt JH et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998; 119:475-80.
8. Feinstein A, Friedman J, Schewach-Millet M. Pachyonychia congenita. J Am Acad Dermatol 1988; 19:705-11.
9. Soyuer U, Candan MF. Failure of etretinate therapy in pachyonychia congenita. Br J Dermatol 1987; 117:264.
10. Su WP, Chun SI, Hammond DE et al. Pachyonychia congenita: a clinical study of 12 cases and review of the literature. Pediatr Dermatol 1990; 7:33-8.